In our study, we demonstrated that CCN1 could regulate lipometabolism and promote hepatocyte apoptosis in the pathogenesis of NASH and could drive macrophage infiltration into the liver, which was consistent with previous studies. Here, CCN1 is linked to metabolic dysfunction-associated steatohepatitis.